已收盤 02-06 16:00:00 美东时间
+5.630
+3.46%
今日重点评级关注:Ascendiant Capital:维持Lucid Diagnostics"买入"评级,目标价从8美元升至8.25美元;Ascendiant Capital:维持Aytu BioPharma"买入"评级,目标价从12.5美元升至13美元
2025-12-11 10:33
Jefferies analyst Saree Boroditsky upgrades JBT Marel (NYSE:JBTM) from Hold to Buy and raises the price target from $150 to $180.
2025-12-10 21:52
JBT (JBTM) declares $0.10/share quarterly dividend, in line with previous. Forward yield 0.28% Payable Dec. 29; for shareholders of record Dec. 15; ex-div Dec. 15. See JBTM Dividend Scorecard, Yield ...
2025-12-05 05:21
JBT Marel shares are trading higher after the company reported better-than-expe...
2025-11-05 00:00
JBT Marel (NYSE:JBTM) raises FY2025 Adj EPS guidance from $5.45-$6.15 to $6.10-$6.40 vs $5.89 analyst estimate. Raises FY2025 sales outlook from $3.675 billion-$3.725 billion to $3.760 billion-$3.790 billion vs $3.706
2025-11-04 05:23
Companies Reporting Before The Bell • CNA Financial (NYSE:CNA) is expected to r...
2025-11-03 19:11
An update from JBT Marel ( ($JBTM) ) is now available. On October 15, 2025, Jes...
2025-10-21 06:08
JBT Marel Corp.于2025年9月9日完成5.75亿美元私募发行,可能引发短期股价波动,但从长期看这笔资金或用于业务扩张、技术研发及债务重组,有望对公司发展产生积极影响。
2025-09-11 05:01
JBT Marel ( ($JBTM) ) has issued an announcement. On September 9, 2025, JBT Mar...
2025-09-10 04:56
JBT Marel Corporation (NYSE and Nasdaq Iceland: JBTM) announced today that it intends to offer $500 million aggregate principal amount of convertible senior notes due 2030 (the "Notes") in a private offering (the
2025-09-04 04:02